Buying a Pharmacy: What It Costs, the Cash You Need at Closing and the SBA Loan Math

An existing independent US pharmacy cost a median $325,000 to buy across 2021 to 2025, and $600,000 at the 2025 median, based on BizBuySell closed sales. Half of the pharmacies that sold went for between 1.69 and 3.75 times seller discretionary earnings, and that price is before inventory, which is counted and paid for separately at closing. With an SBA 7(a) loan on a $325,000 store, the cash you bring is about $39,000 for the equity injection and the guaranty fee, plus inventory and working capital.

The price is the easy part. The harder question is whether the store can pay the loan and pay you, because the median pharmacy that sold earned its owner $150,000 a year, and the median wage for a pharmacist is $140,910.

How much does it cost to buy a pharmacy?

The median pharmacy sold for $325,000, on median revenue of $1,334,270 and median owner earnings of $150,000. Prices rose sharply across the record, from a median $262,500 in 2021 to $600,000 in 2025, but the stores changing hands got bigger too: pharmacies sold in 2025 had median revenue of $2,544,000, against $675,000 in 2021. Those are prices for the business, meaning the script file, fixtures, systems, name and lease rights. Inventory is counted at cost on the closing date and paid on top, and any real estate is priced separately.

Pharmacies trade on a multiple of seller discretionary earnings (SDE), so the useful way to read price is by the earnings of the store in front of you:

The 2.17x column is the median sale price divided by median owner earnings, which is the multiple that reproduces what the typical store closed at. The published median multiple is 2.45x. It sits higher because a median of per-deal ratios is not the same number as a ratio of medians. Script volume, payer mix, cash-pay services and the lease decide which column a store belongs in. The full quartile spread, the five-year record and a comparison against thirteen retail categories are on our pharmacy valuation page.

How much money do you need to buy a pharmacy?

On a $325,000 pharmacy financed with an SBA 7(a) loan, plan on about $39,000 of cash for the equity injection and the SBA guaranty fee, before inventory and working capital. Here is the arithmetic on the five-year median store, with the 2025 median alongside:

Three lines need a note. The guaranty fee is set by the SBA each fiscal year, and for FY2026 loans between $150,001 and $700,000 it is 3 percent of the guaranteed portion. Inventory is the line that surprises buyers most. On a pharmacy it is a real second check, so agree the counting method, the treatment of short-dated and returnable stock, and whether the loan funds it, in the letter of intent rather than the week before closing. Working capital is our own planning figure, sized at a month of revenue because wholesaler invoices come due on their own schedule while reimbursements arrive on the payers' schedule. SBA 7(a) proceeds can include working capital, so ask the lender to size it into the loan.

The valuation line depends on the deal. Under SBA SOP 50 10 8, the lender has to get an independent business valuation when the intangible part of what is financed, after appraised real estate and equipment are taken out, is above $250,000. A pharmacy is mostly intangible, because the script file and the goodwill behind it are what you are paying for. On the $600,000 store, a $540,000 loan against $100,000 of appraised fixtures and equipment leaves $440,000 of intangible value, so the valuation is required. On the $325,000 store it is required if the fixtures and equipment appraise below $42,500. The lender engages the appraiser either way, so a report you commission yourself will not replace it. Our guide to business valuation for an SBA loan covers the threshold, and what a business valuation costs compares the options if you need one.

Can you get an SBA loan to buy a pharmacy?

Yes, and the loan payment is not the problem. Your own salary is. A $292,500 SBA 7(a) loan over 10 years at 10.5 percent costs about $47,362 a year. The median pharmacy's $150,000 of owner earnings covers that 3.17 times, far above the 1.25x coverage most lenders look for, and leaves about $102,638 before the owner is paid anything.

Now pay yourself. The Bureau of Labor Statistics put the median annual wage for pharmacists at $140,910 in May 2025. Take that out of $150,000 and $9,090 is left, which does not come close to covering the debt. Here is the purchase price the median store's earnings support at each level of owner draw, on the same loan terms with 1.25x coverage and a 10 percent injection:

So a pharmacist buying the median store at $325,000 is choosing to earn about $91,000 a year while still passing the lender's coverage test, in exchange for ownership and the equity the loan builds. Plenty of buyers make that trade on purpose. The point is to make it knowingly, and to run the 2025 numbers as well: the median 2025 store earned $186,089, and at a full pharmacist wage it supports only about $248,000 of price against a $600,000 median sale. Rates move with prime, which was reported at 6.75 percent in September 2026, so treat 10.5 percent as a planning figure. Our overview of an SBA loan to buy a business walks through the application, and seller financing a business sale is the usual way to bridge the gap between what a lender funds and what a seller wants.

Is the asking price of a pharmacy what you will pay?

Usually not. Pharmacies close at an average 0.89 of asking price, the second weakest ratio of the thirteen retail categories we compared, and the median sale took 163 days. Listings also describe a different population from the stores that sell. Pharmacies currently for sale ask a median 3.02 times owner earnings, on median owner earnings of $260,000. Pharmacies that sold went for 2.45 times, on $150,000. The listings report 73.3 percent more earnings than the stores that actually close.

So a listing can overstate the price twice, once in the multiple and once in the earnings the multiple is applied to. The sellers who closed were asking about 2.75 times earnings. A pharmacy listed at 4 times owner earnings sits above the upper quartile of what sold, and it needs something specific behind it, such as heavy cash-pay or compounding revenue, before it deserves an offer near the price.

What should you verify before you make an offer?

Verify the earnings, the payer mix and the licences before you negotiate the price. A pharmacy can look healthy on revenue and still hand a new owner a margin problem, so these checks come first:

• Tax returns against the profit and loss statement. Tie three years of returns to the P&L, then recalculate owner earnings yourself using our guide on how to calculate SDE, and price on your number rather than the listing's.
• A twelve month script report by payer. The NCPA Digest found that 52 percent of prescriptions at independent pharmacies in 2024 were covered by Medicare Part D and Medicaid combined. Know this store's share, and how much of its gross margin depends on its largest PBM contract.
• DIR fee normalization. Pharmacy DIR fees moved to the point of sale for contract year 2024. A trailing twelve months that straddles January 2024 does not compare like for like, so ask for the figures restated on the post-2024 basis.
• Licences and contracts. State boards of pharmacy generally require a new permit or a change of ownership filing, and a DEA registration cannot be transferred without the DEA's written consent under 21 CFR 1301.52. PBM network contracts and Medicare and Medicaid enrollment have to follow the sale as well. The store cannot dispense without them, so build those timelines into the closing date.

What costs do pharmacy buyers forget?

• Staffing the counter. Unless you will personally cover every open hour, you are paying a pharmacist-in-charge or relief pharmacists, and payroll is the largest cost you control. Before you sign, benchmark pay bands for the pharmacists and technicians you plan to keep, because a retention raise after closing comes straight out of owner earnings.
• The lease. Being close to the clinics that write the prescriptions is most of the location value, and a lender will not amortize a ten year loan against a short lease. Confirm the remaining term plus options early.
• Systems and wholesaler terms. The pharmacy management system licence and the wholesaler account usually need new agreements, and the credit terms offered to a new owner are negotiated fresh rather than inherited from the seller.
• Due diligence fees. A healthcare attorney, an accountant's review of the books and the inventory count all cost money whether or not the deal closes. Our notes on a letter of intent to purchase a business cover the contingencies that protect that spend.

Is buying a pharmacy worth it at today's prices?

At the five-year median, the numbers work for a pharmacist who accepts a below-market salary for a few years in exchange for owning the store. The 2025 figures need more care. Buyers paid 3.22 times owner earnings in 2025, against 2.25 times in 2021, while the owner margin of the stores that sold fell to 7.3 percent, the lowest of the five years. More of the price now rides on thinner margins.

That does not make a given store a bad buy. It means the price should still make sense at the five-year median multiple of 2.45x and at the salary you actually need to take. Before you make an offer, run the store's verified revenue and owner earnings through an estimate and see which row of the price table above it belongs in. It takes a few minutes, and on a $325,000 purchase the gap between the typical column and the upper quartile column is larger than all the cash you would bring to closing.

The benchmarks in this article come from BizBuySell pharmacy sales for 2021 to 2025, retrieved in September 2026. The SBA figures reflect the FY2026 fee schedule, and the wage figure is the BLS May 2025 median for pharmacists. Every result on this site is an educational estimate, not a certified appraisal.